SlideShare a Scribd company logo
1 of 13
How to Create and Capture
Value Beyond the Pill
“Big Pharma has to move beyond just „selling the pill„ ”
Joseph Jimenez, Novartis CEO
Beyond-the-pill is a logical and inevitable
path forward for all
PAYERS
Rising costs of chronic
disease management –
focus on outcome vs
cost
UNMET NEEDS
Opportunities for improved care
NEW TECHNOLOGIES
New service possibilities
PHARMAS
Increasingly difficult to
differentiate through
pills alone
PATIENTS
Demanding more
support on managing
chronic conditions
Creating value by embedding products into a holistic
offering with the aim to improve patient outcomes and
provide tangible competitive advantages
Executive Insight AG 2
Leading pharma companies have started to experiment
with services beyond-the-pill
Executive Insight AG 3
Innovative solutions that
facilitate shared decision
making between patients and
physicians
„Proteus ingestible sensor for
tracking medication intake
receives FDA clearance“
Integrated care model for
schizophrenia patients in
Germany
 In-house Care Mgt. Subsidiaries:
 Partnerships & Alliances:  Healthcare Stakeholder Collaborations:
 Patient Support Programs:
&
For example:
Done right, significant impacts can be achieved with
services beyond the pill
Executive Insight AG 4
Better Health Outcomes
In outpatient settings, patient assistance program enrolment plus
additional medication services (e.g., counseling, reminders) is
associated with improved disease indicators for patients.
(Tisha Moniek Felder, Jan. 2010,
http://digitalcommons.library.tmc.edu/dissertations/AAI3398971)
Easier Access to Therapy
Especially for newly launched products with delays in coverage
decisions by PBMs, health plans and government payers.
(Suzanne Shelley, Pharmaceutical Commerce, February 26, 2013)
Increased Brand Loyalty
Through the “Lipitor For You” program Pfizer
maintained three times the normal market share
for Lipitor after the first generic hit.
(http://beyondthepill.medivo.com/2012/08/coupons-and-
co-pays-how-a-few-brands-are-battling-generics/)
5
Adding standard off-the-shelf services to a product
is the fast & easy tactical approach
Executive Insight AG
Patient website...
An app... A reminder...
A brochure ...
But these services are often disconnected and
fail to truly address stakeholder needs
Executive Insight AG 6
Awareness
Diagnosis
Monitoring
Fear & anxietyPoor physician-patient
communication
Diagnostics not part
of all check-ups or
not reimbursed
Can a simple brochure deal
with emotional & inter-
personal challenges?
Early symptoms
not recognized
Is an awareness
campaign sufficient?
Therapy
Challenges along a patient‘s journey
Complex
medication for
co-morbid
patients
Side effects and drug-
drug interactions
Is a simple product
information enough?
Can a reminder address
intentional non-adherence?
Intentional & non-
intentional non-
adherence
Social withdrawal,
avoidance, isolation
What about the patient‘s
overall well-being?
Our beyond-the-pill excellence method
ensures a strategic approach
Executive Insight AG 7
Diagnose Define Design Implement
Nature of disease: e.g. no
symptoms / difficult
diagnosis etc.?
Stakeholders: Needs
along the patient journey?
Competition: Minimum
services required to match
offerings?
Brand: Specific
requirement e.g. injection
or first dose monitoring?
Goal of the overall service
strategy?
Fit with product portfolio?
Key components (breadth
& depth of offerings) of
service strategy?
How success is to be
measured?
Priority steps & needs to
be addressed with
services?
How to co-create services
with customers to ensure
relevance and
acceptance?
How to include internal
cross-functional
knowledge and input?
Priority steps & needs to
be addressed with
services?
How to co-create services
with customers to ensure
relevance and
acceptance?
How to include internal
cross-functional
knowledge and input?
What factors drive
the service model?
Which service
strategy?
What services
to offer?
How to implement
the services?
Diagnose: Full understanding of disease, competition
and stakeholder landscape service implications
Executive Insight AG 8
Example of Structured Analyis:
Competition Baseline to match services currently
offered by competitors? Areas of differentiation?
Disease & Brand Nature of the disease &
implication on service? Product fit with the current
disease and therapy settings? Any product features
presenting a need or an opportunity for service
offerings (eg. injection, first dose monitoring)?
Stakeholders Physical, emotional & financial
journey of patient – unmet needs & decision points?
Diagnostic
To understand the implications of the disease,
brand, competition and stakeholder needs for the
service model strategy.
Define: A strategy and service model that best fits you
Executive Insight AG 9
Limited Offering
Generic services targeting one or
few steps in the patient pathway
(e.g. benefits investigation)
LevelofCustomization
Low
High
Breadth of OfferingFew Many
Focused Offering
Highly customized services targeting
one or few steps in the patient
pathway (e.g. emergency on-site
diagnosis for acute indications)
Broad Offering
Bundle of generic services targeting
most steps of the patient pathway
(e.g. blockbuster offering for primary
care indication)
Relationship Offering
Complete solutions that are highly
customized and cover the entire
patient pathway (e.g. complex chronic
specialty indications)
Executive Insight Service Models:
Design: Services that are truly relevant with ownership
and commitment from your customers
Executive Insight AG 10
Collaborate with
stakeholders
along patient journey to fully
understand needs and opportunities
Executive Insight‘s inclusive and collaborative
Deep Dive Methodology
Co-create innovative
solutions with you
by harnessing collective
imaginative power
Process OptimizationDiagnosis Education/Training
Adherence / ComplianceLifestyle/Peer-to-Peer
MonitoringTreatment DecisionAwareness
Access
Tpyes of services created e.g.:
Winning
Beyond-the-Pill
Service Strategy
Implement: Driven towards meeting key success factors
Executive Insight AG 11
Take a needs-based
approach
Patient/stakeholder’s (not the
brand) perspective to address
needs along the patient journey
Consider ALL
stakeholder groups
Other key players beyond
HCP & patients e.g. care-
givers, pharmacists
Co-develop solutions
with customers
Higher relevance and adoption
of service solutions
Clarify ownership &
resourcing
Allocation of funding and
resources pre-launch as well
as early affiliate involvement
Start early
Sufficient lead time for piloting &
implementation with roadmap of
comprehensive service solution
well before launch
Leverage external
partners
Multiple areas of expertise and
multi-country execution
Our experience is already helping to shape
beyond-the-pill thinking in the market
Executive Insight AG 12
Thought-leading publications: Founders of the beyond-the-pill
group on LinkedIn:
http://www.executiveinsight.ch/publications http://www.linkedin.com/groups?gid=4383768&trk=myg_ugrp_ovr
Track record:
Beyond-the-pill projects with
leading global pharma companies
Call us to discuss how you can also develop &
implement a winning beyond-the-pill strategy
Company address
Contacts
Meike Wenzel
Mobile: +41 79 322 12 39
m.wenzel@executiveinsight.ch
Executive Insight AG
Metallstrasse 9
CH-6304 Zug
Tel. +41 (0)41 710 71 63
www.executiveinsight.ch
info@executiveinsight.ch
Marc Pesse
Mobile: +41 78 639 52 43
m.pesse@executiveinsight.ch
Executive Insight AG 13

More Related Content

What's hot

Pharmaceutical marketing in the 21st century
Pharmaceutical marketing in the 21st centuryPharmaceutical marketing in the 21st century
Pharmaceutical marketing in the 21st centuryRamdas Dolas
 
CHAPTER-1 AND CHAPTER-2 PPT OF POM.pptx
CHAPTER-1 AND CHAPTER-2 PPT OF POM.pptxCHAPTER-1 AND CHAPTER-2 PPT OF POM.pptx
CHAPTER-1 AND CHAPTER-2 PPT OF POM.pptxVEENANMAI002515
 
Complete Durable Medical Equipment (DME) Billing Guide | Sun Knowledge
Complete Durable Medical Equipment (DME) Billing Guide | Sun KnowledgeComplete Durable Medical Equipment (DME) Billing Guide | Sun Knowledge
Complete Durable Medical Equipment (DME) Billing Guide | Sun KnowledgeMichael Smith
 
Commercial considerations in early drug development
Commercial considerations in early drug developmentCommercial considerations in early drug development
Commercial considerations in early drug developmentSunil Ramkali
 
Launch your medical product
Launch your medical productLaunch your medical product
Launch your medical productmedteleinc
 
Digital and Social Media in Pharma
Digital and Social Media in PharmaDigital and Social Media in Pharma
Digital and Social Media in PharmaChandradarshan Jain
 
New launching strategy of pharmaceutical brand
New launching strategy of pharmaceutical brandNew launching strategy of pharmaceutical brand
New launching strategy of pharmaceutical brandMohammad Masum Chowdhury
 
Provider-led Health Plans (Payviders)
Provider-led Health Plans (Payviders)Provider-led Health Plans (Payviders)
Provider-led Health Plans (Payviders)CitiusTech
 
Medical Device Business Plan Sample Redacted
Medical Device Business Plan Sample RedactedMedical Device Business Plan Sample Redacted
Medical Device Business Plan Sample RedactedJackson Wu
 
IQVIA- Q3 2022 Industry Presentation.pdf
IQVIA- Q3 2022 Industry Presentation.pdfIQVIA- Q3 2022 Industry Presentation.pdf
IQVIA- Q3 2022 Industry Presentation.pdfAliShahid755835
 
Pharmaceutical Marketing Strategy
Pharmaceutical Marketing StrategyPharmaceutical Marketing Strategy
Pharmaceutical Marketing StrategyAwais e Siraj
 
Strategic Medical Affairs in pharma and medical devices
Strategic Medical Affairs in pharma and medical devicesStrategic Medical Affairs in pharma and medical devices
Strategic Medical Affairs in pharma and medical devicesAnjan Banerjee
 
Optimize Your Launch Sequence Strategies - White Paper
Optimize Your Launch Sequence Strategies - White PaperOptimize Your Launch Sequence Strategies - White Paper
Optimize Your Launch Sequence Strategies - White PaperPatrick Homer
 
Digital strategies in pharmaceutical industry
Digital strategies in pharmaceutical industryDigital strategies in pharmaceutical industry
Digital strategies in pharmaceutical industryMeghavi Mehta
 
How to Make Pharmaceutical Marketing Plan
How to Make Pharmaceutical Marketing PlanHow to Make Pharmaceutical Marketing Plan
How to Make Pharmaceutical Marketing PlanMuhammad Ali Jehangir
 
INTIENT Pharmacovigilance
INTIENT PharmacovigilanceINTIENT Pharmacovigilance
INTIENT Pharmacovigilanceaccenture
 

What's hot (20)

case study-pharma
case study-pharmacase study-pharma
case study-pharma
 
Pharmaceutical marketing in the 21st century
Pharmaceutical marketing in the 21st centuryPharmaceutical marketing in the 21st century
Pharmaceutical marketing in the 21st century
 
CHAPTER-1 AND CHAPTER-2 PPT OF POM.pptx
CHAPTER-1 AND CHAPTER-2 PPT OF POM.pptxCHAPTER-1 AND CHAPTER-2 PPT OF POM.pptx
CHAPTER-1 AND CHAPTER-2 PPT OF POM.pptx
 
Complete Durable Medical Equipment (DME) Billing Guide | Sun Knowledge
Complete Durable Medical Equipment (DME) Billing Guide | Sun KnowledgeComplete Durable Medical Equipment (DME) Billing Guide | Sun Knowledge
Complete Durable Medical Equipment (DME) Billing Guide | Sun Knowledge
 
Commercial considerations in early drug development
Commercial considerations in early drug developmentCommercial considerations in early drug development
Commercial considerations in early drug development
 
IDN 101
IDN 101IDN 101
IDN 101
 
Pharmaceutical Marketing
Pharmaceutical MarketingPharmaceutical Marketing
Pharmaceutical Marketing
 
Launch your medical product
Launch your medical productLaunch your medical product
Launch your medical product
 
Digital and Social Media in Pharma
Digital and Social Media in PharmaDigital and Social Media in Pharma
Digital and Social Media in Pharma
 
New launching strategy of pharmaceutical brand
New launching strategy of pharmaceutical brandNew launching strategy of pharmaceutical brand
New launching strategy of pharmaceutical brand
 
Provider-led Health Plans (Payviders)
Provider-led Health Plans (Payviders)Provider-led Health Plans (Payviders)
Provider-led Health Plans (Payviders)
 
Medical Device Business Plan Sample Redacted
Medical Device Business Plan Sample RedactedMedical Device Business Plan Sample Redacted
Medical Device Business Plan Sample Redacted
 
IQVIA- Q3 2022 Industry Presentation.pdf
IQVIA- Q3 2022 Industry Presentation.pdfIQVIA- Q3 2022 Industry Presentation.pdf
IQVIA- Q3 2022 Industry Presentation.pdf
 
Pharmaceutical Marketing Strategy
Pharmaceutical Marketing StrategyPharmaceutical Marketing Strategy
Pharmaceutical Marketing Strategy
 
Strategic Medical Affairs in pharma and medical devices
Strategic Medical Affairs in pharma and medical devicesStrategic Medical Affairs in pharma and medical devices
Strategic Medical Affairs in pharma and medical devices
 
Optimize Your Launch Sequence Strategies - White Paper
Optimize Your Launch Sequence Strategies - White PaperOptimize Your Launch Sequence Strategies - White Paper
Optimize Your Launch Sequence Strategies - White Paper
 
Introduction to pharmacy business models
Introduction to pharmacy business modelsIntroduction to pharmacy business models
Introduction to pharmacy business models
 
Digital strategies in pharmaceutical industry
Digital strategies in pharmaceutical industryDigital strategies in pharmaceutical industry
Digital strategies in pharmaceutical industry
 
How to Make Pharmaceutical Marketing Plan
How to Make Pharmaceutical Marketing PlanHow to Make Pharmaceutical Marketing Plan
How to Make Pharmaceutical Marketing Plan
 
INTIENT Pharmacovigilance
INTIENT PharmacovigilanceINTIENT Pharmacovigilance
INTIENT Pharmacovigilance
 

Viewers also liked

Value Beyond The Pill: The Possibilities That Technology Offers Healthcare
Value Beyond The Pill: The Possibilities That Technology Offers HealthcareValue Beyond The Pill: The Possibilities That Technology Offers Healthcare
Value Beyond The Pill: The Possibilities That Technology Offers HealthcareFleishmanHillard UK
 
Five Steps to Find your 'Beyond the Pill' Strategy
Five Steps to Find your 'Beyond the Pill' StrategyFive Steps to Find your 'Beyond the Pill' Strategy
Five Steps to Find your 'Beyond the Pill' Strategyexecutiveinsight
 
Pharma "beyond the pil" - master class in St.Petersburg
Pharma "beyond the pil" - master class in St.PetersburgPharma "beyond the pil" - master class in St.Petersburg
Pharma "beyond the pil" - master class in St.PetersburgA.R.J. (Rob) Halkes
 
Beyond-the-pill: how to move from selling pills to value-added solutions
Beyond-the-pill: how to move from selling pills to value-added solutionsBeyond-the-pill: how to move from selling pills to value-added solutions
Beyond-the-pill: how to move from selling pills to value-added solutionsexecutiveinsight
 
Redefining the role of patient support programs: Shifting the focus towards p...
Redefining the role of patient support programs: Shifting the focus towards p...Redefining the role of patient support programs: Shifting the focus towards p...
Redefining the role of patient support programs: Shifting the focus towards p...SKIM
 
The new pharma, customer centric, databased business model
The new pharma, customer centric, databased business modelThe new pharma, customer centric, databased business model
The new pharma, customer centric, databased business modelA.R.J. (Rob) Halkes
 
eHealth and digital health - Intro to learn
eHealth and digital health - Intro to learn eHealth and digital health - Intro to learn
eHealth and digital health - Intro to learn A.R.J. (Rob) Halkes
 
Creating value through patient support programs
Creating value through patient support programsCreating value through patient support programs
Creating value through patient support programsSKIM
 
Digital Health Funding 2014 Midyear Report by @Rock_Health
Digital Health Funding 2014 Midyear Report by @Rock_HealthDigital Health Funding 2014 Midyear Report by @Rock_Health
Digital Health Funding 2014 Midyear Report by @Rock_HealthRock Health
 
Digital trends in healthcare and pharma marketing
Digital trends in healthcare and pharma marketingDigital trends in healthcare and pharma marketing
Digital trends in healthcare and pharma marketingGSW
 

Viewers also liked (12)

Value Beyond The Pill: The Possibilities That Technology Offers Healthcare
Value Beyond The Pill: The Possibilities That Technology Offers HealthcareValue Beyond The Pill: The Possibilities That Technology Offers Healthcare
Value Beyond The Pill: The Possibilities That Technology Offers Healthcare
 
Five Steps to Find your 'Beyond the Pill' Strategy
Five Steps to Find your 'Beyond the Pill' StrategyFive Steps to Find your 'Beyond the Pill' Strategy
Five Steps to Find your 'Beyond the Pill' Strategy
 
Pharma "beyond the pil" - master class in St.Petersburg
Pharma "beyond the pil" - master class in St.PetersburgPharma "beyond the pil" - master class in St.Petersburg
Pharma "beyond the pil" - master class in St.Petersburg
 
Beyond-the-pill: how to move from selling pills to value-added solutions
Beyond-the-pill: how to move from selling pills to value-added solutionsBeyond-the-pill: how to move from selling pills to value-added solutions
Beyond-the-pill: how to move from selling pills to value-added solutions
 
How to Deliver Value "Beyond the Pill"
How to Deliver Value "Beyond the Pill"How to Deliver Value "Beyond the Pill"
How to Deliver Value "Beyond the Pill"
 
Redefining the role of patient support programs: Shifting the focus towards p...
Redefining the role of patient support programs: Shifting the focus towards p...Redefining the role of patient support programs: Shifting the focus towards p...
Redefining the role of patient support programs: Shifting the focus towards p...
 
The new pharma, customer centric, databased business model
The new pharma, customer centric, databased business modelThe new pharma, customer centric, databased business model
The new pharma, customer centric, databased business model
 
Bayer's digital strategy
Bayer's digital strategyBayer's digital strategy
Bayer's digital strategy
 
eHealth and digital health - Intro to learn
eHealth and digital health - Intro to learn eHealth and digital health - Intro to learn
eHealth and digital health - Intro to learn
 
Creating value through patient support programs
Creating value through patient support programsCreating value through patient support programs
Creating value through patient support programs
 
Digital Health Funding 2014 Midyear Report by @Rock_Health
Digital Health Funding 2014 Midyear Report by @Rock_HealthDigital Health Funding 2014 Midyear Report by @Rock_Health
Digital Health Funding 2014 Midyear Report by @Rock_Health
 
Digital trends in healthcare and pharma marketing
Digital trends in healthcare and pharma marketingDigital trends in healthcare and pharma marketing
Digital trends in healthcare and pharma marketing
 

Similar to Creating value beyond the pill

VBBD Webinar Dec 2010
VBBD Webinar Dec 2010VBBD Webinar Dec 2010
VBBD Webinar Dec 2010archanasunil
 
VBBD Webinar Dec 2010
VBBD Webinar Dec 2010VBBD Webinar Dec 2010
VBBD Webinar Dec 2010archanasunil
 
Value Innovation To Pharma - What Changes To Busisness, Zurich 2008
Value Innovation To Pharma - What Changes To Busisness, Zurich 2008Value Innovation To Pharma - What Changes To Busisness, Zurich 2008
Value Innovation To Pharma - What Changes To Busisness, Zurich 2008A.R.J. (Rob) Halkes
 
Promotional Effectiveness 2010
Promotional Effectiveness 2010Promotional Effectiveness 2010
Promotional Effectiveness 2010henso010
 
Daniel Jackson, UCB
Daniel Jackson, UCBDaniel Jackson, UCB
Daniel Jackson, UCBGoPrezi
 
A new foundation for designing winning brand strategies The Patient Journey r...
A new foundation for designing winning brand strategies The Patient Journey r...A new foundation for designing winning brand strategies The Patient Journey r...
A new foundation for designing winning brand strategies The Patient Journey r...Shishir Tiwary
 
Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...
Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...
Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...No Fixed Address Health
 
Social Marketing Workshop - Part 2
Social Marketing Workshop - Part 2Social Marketing Workshop - Part 2
Social Marketing Workshop - Part 2Stephan Dahl
 
Influence of pharmaceutical marketing on
Influence of pharmaceutical marketing onInfluence of pharmaceutical marketing on
Influence of pharmaceutical marketing onMdIrfanUddin2
 
ESL Pharmaceuticals: Patient-centric care
ESL Pharmaceuticals: Patient-centric careESL Pharmaceuticals: Patient-centric care
ESL Pharmaceuticals: Patient-centric careKatieEnglishTutoring
 
Avident deck crowdfunding 3 21 18 slideshare
Avident deck crowdfunding 3 21 18 slideshareAvident deck crowdfunding 3 21 18 slideshare
Avident deck crowdfunding 3 21 18 slideshareMaen Farha
 
The Complete Guide to Wellness Software Development
The Complete Guide to Wellness Software DevelopmentThe Complete Guide to Wellness Software Development
The Complete Guide to Wellness Software DevelopmentMentorMate
 
The Patient Journey
The Patient JourneyThe Patient Journey
The Patient JourneyCovance
 
Towards Value Innovation In Pharma SFE Conference London 062007
Towards Value Innovation In Pharma SFE Conference London 062007Towards Value Innovation In Pharma SFE Conference London 062007
Towards Value Innovation In Pharma SFE Conference London 062007A.R.J. (Rob) Halkes
 
NCCR'16 Deloitte Presentation Karin Wellbrock 20160715
NCCR'16 Deloitte Presentation Karin Wellbrock 20160715NCCR'16 Deloitte Presentation Karin Wellbrock 20160715
NCCR'16 Deloitte Presentation Karin Wellbrock 20160715Karin Jork-Wellbrock
 
Case Study of Patient Experience Design & Marketing Management: Baystate Brea...
Case Study of Patient Experience Design & Marketing Management: Baystate Brea...Case Study of Patient Experience Design & Marketing Management: Baystate Brea...
Case Study of Patient Experience Design & Marketing Management: Baystate Brea...Renown Health
 
Ensuring Profitable Patient Adherence Programs (mini)
Ensuring Profitable Patient Adherence Programs  (mini)Ensuring Profitable Patient Adherence Programs  (mini)
Ensuring Profitable Patient Adherence Programs (mini)Eularis
 

Similar to Creating value beyond the pill (20)

VBBD Webinar Dec 2010
VBBD Webinar Dec 2010VBBD Webinar Dec 2010
VBBD Webinar Dec 2010
 
VBBD Webinar Dec 2010
VBBD Webinar Dec 2010VBBD Webinar Dec 2010
VBBD Webinar Dec 2010
 
Value Innovation To Pharma - What Changes To Busisness, Zurich 2008
Value Innovation To Pharma - What Changes To Busisness, Zurich 2008Value Innovation To Pharma - What Changes To Busisness, Zurich 2008
Value Innovation To Pharma - What Changes To Busisness, Zurich 2008
 
Promotional Effectiveness 2010
Promotional Effectiveness 2010Promotional Effectiveness 2010
Promotional Effectiveness 2010
 
Daniel Jackson, UCB
Daniel Jackson, UCBDaniel Jackson, UCB
Daniel Jackson, UCB
 
A new foundation for designing winning brand strategies The Patient Journey r...
A new foundation for designing winning brand strategies The Patient Journey r...A new foundation for designing winning brand strategies The Patient Journey r...
A new foundation for designing winning brand strategies The Patient Journey r...
 
Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...
Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...
Navigating the Future of Healthcare at the Intersection of HCPs, Patients, an...
 
Social Marketing Workshop - Part 2
Social Marketing Workshop - Part 2Social Marketing Workshop - Part 2
Social Marketing Workshop - Part 2
 
Influence of pharmaceutical marketing on
Influence of pharmaceutical marketing onInfluence of pharmaceutical marketing on
Influence of pharmaceutical marketing on
 
ESL Pharmaceuticals: Patient-centric care
ESL Pharmaceuticals: Patient-centric careESL Pharmaceuticals: Patient-centric care
ESL Pharmaceuticals: Patient-centric care
 
Avident deck crowdfunding 3 21 18 slideshare
Avident deck crowdfunding 3 21 18 slideshareAvident deck crowdfunding 3 21 18 slideshare
Avident deck crowdfunding 3 21 18 slideshare
 
The Complete Guide to Wellness Software Development
The Complete Guide to Wellness Software DevelopmentThe Complete Guide to Wellness Software Development
The Complete Guide to Wellness Software Development
 
The Patient Journey
The Patient JourneyThe Patient Journey
The Patient Journey
 
Towards Value Innovation In Pharma SFE Conference London 062007
Towards Value Innovation In Pharma SFE Conference London 062007Towards Value Innovation In Pharma SFE Conference London 062007
Towards Value Innovation In Pharma SFE Conference London 062007
 
NCCR'16 Deloitte Presentation Karin Wellbrock 20160715
NCCR'16 Deloitte Presentation Karin Wellbrock 20160715NCCR'16 Deloitte Presentation Karin Wellbrock 20160715
NCCR'16 Deloitte Presentation Karin Wellbrock 20160715
 
Adherence product plan v6.1
Adherence product plan v6.1Adherence product plan v6.1
Adherence product plan v6.1
 
Ambulatory Solutions
Ambulatory SolutionsAmbulatory Solutions
Ambulatory Solutions
 
Case Study of Patient Experience Design & Marketing Management: Baystate Brea...
Case Study of Patient Experience Design & Marketing Management: Baystate Brea...Case Study of Patient Experience Design & Marketing Management: Baystate Brea...
Case Study of Patient Experience Design & Marketing Management: Baystate Brea...
 
Magazine Sample 1
Magazine Sample 1Magazine Sample 1
Magazine Sample 1
 
Ensuring Profitable Patient Adherence Programs (mini)
Ensuring Profitable Patient Adherence Programs  (mini)Ensuring Profitable Patient Adherence Programs  (mini)
Ensuring Profitable Patient Adherence Programs (mini)
 

More from executiveinsight

Early Value Definition: A paradigm shift
Early Value Definition: A paradigm shiftEarly Value Definition: A paradigm shift
Early Value Definition: A paradigm shiftexecutiveinsight
 
Achieving patient centricity
Achieving patient centricityAchieving patient centricity
Achieving patient centricityexecutiveinsight
 
Market Access for Specialty Products in Latin America
Market Access for Specialty Products in Latin AmericaMarket Access for Specialty Products in Latin America
Market Access for Specialty Products in Latin Americaexecutiveinsight
 
Initiating early access programmes: 5 things to consider
Initiating early access programmes: 5 things to considerInitiating early access programmes: 5 things to consider
Initiating early access programmes: 5 things to considerexecutiveinsight
 
Biologics: the next patent cliff
Biologics: the next patent cliffBiologics: the next patent cliff
Biologics: the next patent cliffexecutiveinsight
 
Personalized Medicine: Uptake Challenges
Personalized Medicine: Uptake ChallengesPersonalized Medicine: Uptake Challenges
Personalized Medicine: Uptake Challengesexecutiveinsight
 
Market Access - Getting ready for Personalized Medicine!
Market Access - Getting ready for Personalized Medicine!Market Access - Getting ready for Personalized Medicine!
Market Access - Getting ready for Personalized Medicine!executiveinsight
 
Market Access - Getting ready for Personalized Medicine!
Market Access - Getting ready for Personalized Medicine!Market Access - Getting ready for Personalized Medicine!
Market Access - Getting ready for Personalized Medicine!executiveinsight
 
5 powerful ideas on KOL network management
5 powerful ideas on KOL network management5 powerful ideas on KOL network management
5 powerful ideas on KOL network managementexecutiveinsight
 
10 essential questions for successful kol management
10 essential questions for successful kol management10 essential questions for successful kol management
10 essential questions for successful kol managementexecutiveinsight
 

More from executiveinsight (10)

Early Value Definition: A paradigm shift
Early Value Definition: A paradigm shiftEarly Value Definition: A paradigm shift
Early Value Definition: A paradigm shift
 
Achieving patient centricity
Achieving patient centricityAchieving patient centricity
Achieving patient centricity
 
Market Access for Specialty Products in Latin America
Market Access for Specialty Products in Latin AmericaMarket Access for Specialty Products in Latin America
Market Access for Specialty Products in Latin America
 
Initiating early access programmes: 5 things to consider
Initiating early access programmes: 5 things to considerInitiating early access programmes: 5 things to consider
Initiating early access programmes: 5 things to consider
 
Biologics: the next patent cliff
Biologics: the next patent cliffBiologics: the next patent cliff
Biologics: the next patent cliff
 
Personalized Medicine: Uptake Challenges
Personalized Medicine: Uptake ChallengesPersonalized Medicine: Uptake Challenges
Personalized Medicine: Uptake Challenges
 
Market Access - Getting ready for Personalized Medicine!
Market Access - Getting ready for Personalized Medicine!Market Access - Getting ready for Personalized Medicine!
Market Access - Getting ready for Personalized Medicine!
 
Market Access - Getting ready for Personalized Medicine!
Market Access - Getting ready for Personalized Medicine!Market Access - Getting ready for Personalized Medicine!
Market Access - Getting ready for Personalized Medicine!
 
5 powerful ideas on KOL network management
5 powerful ideas on KOL network management5 powerful ideas on KOL network management
5 powerful ideas on KOL network management
 
10 essential questions for successful kol management
10 essential questions for successful kol management10 essential questions for successful kol management
10 essential questions for successful kol management
 

Recently uploaded

ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATROKanhu Charan
 
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...marcuskenyatta275
 
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...bkling
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsYash Garg
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالةMohamad محمد Al-Gailani الكيلاني
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxDr. Sohan Biswas
 
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSachin Sharma
 
Premium ℂall Girls In Mira Road👉 Dail ℂALL ME: 📞9004268417 📲 ℂall Richa VIP ℂ...
Premium ℂall Girls In Mira Road👉 Dail ℂALL ME: 📞9004268417 📲 ℂall Richa VIP ℂ...Premium ℂall Girls In Mira Road👉 Dail ℂALL ME: 📞9004268417 📲 ℂall Richa VIP ℂ...
Premium ℂall Girls In Mira Road👉 Dail ℂALL ME: 📞9004268417 📲 ℂall Richa VIP ℂ...Rabia Malik
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...Ayman Seddik
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Anjali Parmar
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerSherrylee83
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDr.shiva sai vemula
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxDr. Rabia Inam Gandapore
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answersShafnaP5
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cancer Institute NSW
 
Evidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapyEvidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapyNehaa Dubey
 
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Health Kinesiology Natural Bioenergetics
 
Dermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfDermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfniloofarbarzegari76
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxSamar Tharwat
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale nowSherrylee83
 

Recently uploaded (20)

ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATROROSE  CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
ROSE CASE SPINAL SBRT BY DR KANHU CHARAN PATRO
 
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
 
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
Let's Talk About It: Ovarian Cancer (The Emotional Toll of Treatment Decision...
 
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depthsUnveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
Unveiling Alcohol Withdrawal Syndrome: exploring it's hidden depths
 
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالةGallbladder Double-Diverticular: A Case Report  المرارة مزدوجة التج: تقرير حالة
Gallbladder Double-Diverticular: A Case Report المرارة مزدوجة التج: تقرير حالة
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
 
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
 
Premium ℂall Girls In Mira Road👉 Dail ℂALL ME: 📞9004268417 📲 ℂall Richa VIP ℂ...
Premium ℂall Girls In Mira Road👉 Dail ℂALL ME: 📞9004268417 📲 ℂall Richa VIP ℂ...Premium ℂall Girls In Mira Road👉 Dail ℂALL ME: 📞9004268417 📲 ℂall Richa VIP ℂ...
Premium ℂall Girls In Mira Road👉 Dail ℂALL ME: 📞9004268417 📲 ℂall Richa VIP ℂ...
 
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...Renal Replacement Therapy in Acute Kidney Injury -time  modality -Dr Ayman Se...
Renal Replacement Therapy in Acute Kidney Injury -time modality -Dr Ayman Se...
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)
 
Evidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapyEvidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapy
 
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
 
Dermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdfDermatome and myotome test & pathology.pdf
Dermatome and myotome test & pathology.pdf
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
5CL-ADB powder supplier 5cl adb 5cladba 5cl raw materials vendor on sale now
 

Creating value beyond the pill

  • 1. How to Create and Capture Value Beyond the Pill “Big Pharma has to move beyond just „selling the pill„ ” Joseph Jimenez, Novartis CEO
  • 2. Beyond-the-pill is a logical and inevitable path forward for all PAYERS Rising costs of chronic disease management – focus on outcome vs cost UNMET NEEDS Opportunities for improved care NEW TECHNOLOGIES New service possibilities PHARMAS Increasingly difficult to differentiate through pills alone PATIENTS Demanding more support on managing chronic conditions Creating value by embedding products into a holistic offering with the aim to improve patient outcomes and provide tangible competitive advantages Executive Insight AG 2
  • 3. Leading pharma companies have started to experiment with services beyond-the-pill Executive Insight AG 3 Innovative solutions that facilitate shared decision making between patients and physicians „Proteus ingestible sensor for tracking medication intake receives FDA clearance“ Integrated care model for schizophrenia patients in Germany  In-house Care Mgt. Subsidiaries:  Partnerships & Alliances:  Healthcare Stakeholder Collaborations:  Patient Support Programs: & For example:
  • 4. Done right, significant impacts can be achieved with services beyond the pill Executive Insight AG 4 Better Health Outcomes In outpatient settings, patient assistance program enrolment plus additional medication services (e.g., counseling, reminders) is associated with improved disease indicators for patients. (Tisha Moniek Felder, Jan. 2010, http://digitalcommons.library.tmc.edu/dissertations/AAI3398971) Easier Access to Therapy Especially for newly launched products with delays in coverage decisions by PBMs, health plans and government payers. (Suzanne Shelley, Pharmaceutical Commerce, February 26, 2013) Increased Brand Loyalty Through the “Lipitor For You” program Pfizer maintained three times the normal market share for Lipitor after the first generic hit. (http://beyondthepill.medivo.com/2012/08/coupons-and- co-pays-how-a-few-brands-are-battling-generics/)
  • 5. 5 Adding standard off-the-shelf services to a product is the fast & easy tactical approach Executive Insight AG Patient website... An app... A reminder... A brochure ...
  • 6. But these services are often disconnected and fail to truly address stakeholder needs Executive Insight AG 6 Awareness Diagnosis Monitoring Fear & anxietyPoor physician-patient communication Diagnostics not part of all check-ups or not reimbursed Can a simple brochure deal with emotional & inter- personal challenges? Early symptoms not recognized Is an awareness campaign sufficient? Therapy Challenges along a patient‘s journey Complex medication for co-morbid patients Side effects and drug- drug interactions Is a simple product information enough? Can a reminder address intentional non-adherence? Intentional & non- intentional non- adherence Social withdrawal, avoidance, isolation What about the patient‘s overall well-being?
  • 7. Our beyond-the-pill excellence method ensures a strategic approach Executive Insight AG 7 Diagnose Define Design Implement Nature of disease: e.g. no symptoms / difficult diagnosis etc.? Stakeholders: Needs along the patient journey? Competition: Minimum services required to match offerings? Brand: Specific requirement e.g. injection or first dose monitoring? Goal of the overall service strategy? Fit with product portfolio? Key components (breadth & depth of offerings) of service strategy? How success is to be measured? Priority steps & needs to be addressed with services? How to co-create services with customers to ensure relevance and acceptance? How to include internal cross-functional knowledge and input? Priority steps & needs to be addressed with services? How to co-create services with customers to ensure relevance and acceptance? How to include internal cross-functional knowledge and input? What factors drive the service model? Which service strategy? What services to offer? How to implement the services?
  • 8. Diagnose: Full understanding of disease, competition and stakeholder landscape service implications Executive Insight AG 8 Example of Structured Analyis: Competition Baseline to match services currently offered by competitors? Areas of differentiation? Disease & Brand Nature of the disease & implication on service? Product fit with the current disease and therapy settings? Any product features presenting a need or an opportunity for service offerings (eg. injection, first dose monitoring)? Stakeholders Physical, emotional & financial journey of patient – unmet needs & decision points? Diagnostic To understand the implications of the disease, brand, competition and stakeholder needs for the service model strategy.
  • 9. Define: A strategy and service model that best fits you Executive Insight AG 9 Limited Offering Generic services targeting one or few steps in the patient pathway (e.g. benefits investigation) LevelofCustomization Low High Breadth of OfferingFew Many Focused Offering Highly customized services targeting one or few steps in the patient pathway (e.g. emergency on-site diagnosis for acute indications) Broad Offering Bundle of generic services targeting most steps of the patient pathway (e.g. blockbuster offering for primary care indication) Relationship Offering Complete solutions that are highly customized and cover the entire patient pathway (e.g. complex chronic specialty indications) Executive Insight Service Models:
  • 10. Design: Services that are truly relevant with ownership and commitment from your customers Executive Insight AG 10 Collaborate with stakeholders along patient journey to fully understand needs and opportunities Executive Insight‘s inclusive and collaborative Deep Dive Methodology Co-create innovative solutions with you by harnessing collective imaginative power Process OptimizationDiagnosis Education/Training Adherence / ComplianceLifestyle/Peer-to-Peer MonitoringTreatment DecisionAwareness Access Tpyes of services created e.g.:
  • 11. Winning Beyond-the-Pill Service Strategy Implement: Driven towards meeting key success factors Executive Insight AG 11 Take a needs-based approach Patient/stakeholder’s (not the brand) perspective to address needs along the patient journey Consider ALL stakeholder groups Other key players beyond HCP & patients e.g. care- givers, pharmacists Co-develop solutions with customers Higher relevance and adoption of service solutions Clarify ownership & resourcing Allocation of funding and resources pre-launch as well as early affiliate involvement Start early Sufficient lead time for piloting & implementation with roadmap of comprehensive service solution well before launch Leverage external partners Multiple areas of expertise and multi-country execution
  • 12. Our experience is already helping to shape beyond-the-pill thinking in the market Executive Insight AG 12 Thought-leading publications: Founders of the beyond-the-pill group on LinkedIn: http://www.executiveinsight.ch/publications http://www.linkedin.com/groups?gid=4383768&trk=myg_ugrp_ovr Track record: Beyond-the-pill projects with leading global pharma companies
  • 13. Call us to discuss how you can also develop & implement a winning beyond-the-pill strategy Company address Contacts Meike Wenzel Mobile: +41 79 322 12 39 m.wenzel@executiveinsight.ch Executive Insight AG Metallstrasse 9 CH-6304 Zug Tel. +41 (0)41 710 71 63 www.executiveinsight.ch info@executiveinsight.ch Marc Pesse Mobile: +41 78 639 52 43 m.pesse@executiveinsight.ch Executive Insight AG 13